Search Result "amyloid clearance"
Clearance of Beta-Amyloid in the Brain
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 35 Year: 2014 Page: 4085-4090
Author(s): Masaki Ueno,Yoichi Chiba,Koichi Matsumoto,Toshitaka Nakagawa,Hiroshi Miyanaka
A Role for P-Glycoprotein in Clearance of Alzheimer Amyloid β -Peptide from the Brain
Journal: Current Alzheimer Research
Volume: 13 Issue: 6 Year: 2016 Page: 615-620
Author(s): Wei Wang,Angela M. Bodles-Brakhop,Steven W. Barger
Perspectives for Drug Intervention in Amyloid Diseases
Journal: Current Drug Targets
Volume: 5 Issue: 2 Year: 2004 Page: 151-158
Author(s): Simon Kolstoe, Steve Wood
LRP-Mediated Clearance of Aβ is Inhibited by KPI-Containing Isoforms of APP
Journal: Current Alzheimer Research
Volume: 2 Issue: 2 Year: 2005 Page: 269-273
Author(s): Robert D. Moir, Rudolph E. Tanzi
Clearance of Amyloid-β Peptide by Neuronal and Non-Neuronal Cells: Proteolytic Degradation by Secreted and Membrane associated Proteases
Journal: Current Neurovascular Research
Volume: 4 Issue: 4 Year: 2007 Page: 240-251
Author(s): Mai Panchal, Noureddine Lazar, Noeli Munoz, Christine Fahy, Christine Clamagirand, Jean-Paul Brouard, Lionel Dubost, Paul Cohen, Noureddine Brakch, Mohamed Rholam
Anti-Amyloid Treatments in Alzheimers Disease
Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 4 Issue: 2 Year: 2009 Page: 143-148
Author(s): Mamta Sapra, Kye Y. Kim
Melatonin Treatment Enhances Aβ Lymphatic Clearance in a Transgenic Mouse Model of Amyloidosis
Journal: Current Alzheimer Research
Volume: 15 Issue: 7 Year: 2018 Page: 637-642
Author(s): M.A. Pappolla,E. Matsubara,R. Vidal,J. Pacheco-Quinto,B. Poeggeler,M. Zagorski,K. Sambamurti
Peptidases, Proteases and Amyloid β-Peptide Catabolism
Journal: Current Pharmaceutical Design
Volume: 9 Issue: 6 Year: 2003 Page: 449-454
Author(s): Louis B. Hersh
Blood-Brain-Barrier Models for the Investigation of Transporter- and Receptor-Mediated Amyloid-β Clearance in Alzheimers Disease
Journal: Current Alzheimer Research
Volume: 7 Issue: 7 Year: 2010 Page: 578-590
Author(s): T. Pflanzner, C. R. Kuhlmann, C. U. Pietrzik
Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer,s Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
Journal: Current Alzheimer Research
Volume: 13 Issue: 4 Year: 2016 Page: 403-412
Author(s): José JoaquÃn Merino,Vilma Muñetón-Gómez,MarÃa-Isabel Alvárez,Adolfo Toledano-DÃaz